Ocrelizumab is one of three B-cell therapies approved by the FDA to treat MS. This medicine sticks to B cells and keeps them from causing damage. It has the approval to treat: Clinically isolated ...

The review article highlights the many ways that multiple sclerosis (MS) affects women over the lifespan, from pregnancy to childbirth to menopause and beyond—and how both research and clinical ...

A team of researchers at Kessler Foundation studied the effects of methylphenidate on mental fatigue in individuals with multiple sclerosis (MS). This is the first study to examine the psychostimulant ...

Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system, affecting the brain, spinal cord and optic nerves, leading to a myriad of symptoms, from vision loss and pain to ...

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...

The multiple sclerosis (MS) therapy alemtuzumab can trigger severe, unpredictable side effects. This was the finding by a team led by Prof Dr Aiden Haghikia and Prof Dr Ralf Gold from the Department ...

Share on Pinterest Doctors expect people with MS will stick to their treatments with Vumerity because it has fewer side effects. Getty Images The FDA has approved Vumerity, a new drug to treat ...

The primary outcome measure of the study was the frequency of any adverse psychiatric effect observed during treatment with one of these agents. A review of several second-generation disease-modifying ...

Dr. J. William Lindsey, Director of Multiple Sclerosis and Neuroimmunology at McGovern Medical School, UTHealth Houston, discusses how these social determinants of health impact the disease. (2:35) Is ...